X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA AUROBINDO PHARMA PLETHICO PHARMA/
AUROBINDO PHARMA
 
P/E (TTM) x -1.1 17.7 - View Chart
P/BV x 0.0 5.8 0.3% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 PLETHICO PHARMA   AUROBINDO PHARMA
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
AUROBINDO PHARMA
Mar-16
PLETHICO PHARMA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs3951,541 25.6%   
Low Rs31582 5.4%   
Sales per share (Unadj.) Rs604.4237.5 254.5%  
Earnings per share (Unadj.) Rs32.533.9 95.9%  
Cash flow per share (Unadj.) Rs51.340.6 126.5%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs473.6120.6 392.7%  
Shares outstanding (eoy) m34.08585.17 5.8%   
Bonus/Rights/Conversions -PREF-  
Price / Sales ratio x0.44.5 7.9%   
Avg P/E ratio x6.631.3 20.9%  
P/CF ratio (eoy) x4.226.2 15.9%  
Price / Book Value ratio x0.58.8 5.1%  
Dividend payout %07.4 0.0%   
Avg Mkt Cap Rs m7,262621,041 1.2%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m1,59615,508 10.3%   
Avg. sales/employee Rs ThNM10,457.6-  
Avg. wages/employee Rs ThNM1,167.1-  
Avg. net profit/employee Rs ThNM1,491.6-  
INCOME DATA
Net Sales Rs m20,598138,961 14.8%  
Other income Rs m3861,663 23.2%   
Total revenues Rs m20,984140,624 14.9%   
Gross profit Rs m2,81832,056 8.8%  
Depreciation Rs m6423,926 16.4%   
Interest Rs m1,5932,568 62.1%   
Profit before tax Rs m96927,225 3.6%   
Minority Interest Rs m039 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1387,444 -1.9%   
Profit after tax Rs m1,10719,820 5.6%  
Gross profit margin %13.723.1 59.3%  
Effective tax rate %-14.327.3 -52.3%   
Net profit margin %5.414.3 37.7%  
BALANCE SHEET DATA
Current assets Rs m18,877100,015 18.9%   
Current liabilities Rs m11,89674,759 15.9%   
Net working cap to sales %33.918.2 186.5%  
Current ratio x1.61.3 118.6%  
Inventory Days Days36107 33.5%  
Debtors Days Days198110 180.5%  
Net fixed assets Rs m9,86152,350 18.8%   
Share capital Rs m341585 58.2%   
"Free" reserves Rs m12,33167,707 18.2%   
Net worth Rs m16,13970,567 22.9%   
Long term debt Rs m4,7068,472 55.5%   
Total assets Rs m33,146156,994 21.1%  
Interest coverage x1.611.6 13.9%   
Debt to equity ratio x0.30.1 242.9%  
Sales to assets ratio x0.60.9 70.2%   
Return on assets %8.114.3 57.1%  
Return on equity %6.928.1 24.4%  
Return on capital %12.337.7 32.6%  
Exports to sales %21.451.0 41.9%   
Imports to sales %15.218.8 80.8%   
Exports (fob) Rs m4,40270,927 6.2%   
Imports (cif) Rs m3,13626,193 12.0%   
Fx inflow Rs m4,40271,015 6.2%   
Fx outflow Rs m3,18428,799 11.1%   
Net fx Rs m1,21942,216 2.9%   
CASH FLOW
From Operations Rs m2,43717,596 13.9%  
From Investments Rs m-6,265-13,801 45.4%  
From Financial Activity Rs m2,490-198 -1,255.7%  
Net Cashflow Rs m-1,3373,597 -37.2%  

Share Holding

Indian Promoters % 82.7 54.1 152.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 8.0 54.1%  
FIIs % 5.5 27.7 19.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 10.2 73.5%  
Shareholders   10,665 69,601 15.3%  
Pledged promoter(s) holding % 85.7 8.6 1,001.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   WYETH LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  SUN PHARMA  PFIZER  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - BIOCON LTD COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS